NFATC2 and diabetic kidney disease: Prognostic analysis and enrichment analysis of ‘dark’ genes show that NFATC2 indirectly affects PGI2 production in VEGF signaling pathway, which has a certain impact on the treatment of diabetic nephropathy and can be used as a potential therapeutic drug target.